Roberta Venè

Metagenomic analysis of gut microbiota modulatory effects of jujube (Ziziphus jujuba Mill.) polysaccharides in a colorectal cancer mouse model

Mechanisms of tumor escape from immune system: Role of mesenchymal stromal cells

Triterpenoids as new promising anticancer drugs

The biology and function of fibroblasts in cancer

Natural products for treating colorectal cancer: A mechanistic review

Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

Biotransformations and biological activities of hop flavonoids

Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses

Natural Polyphenols for Prevention and Treatment of Cancer

Inositol Hexaphosphate Suppresses Growth and Induces Apoptosis in Prostate Carcinoma Cells in Culture and Nude Mouse Xenograft: PI3K-Akt Pathway as Potential Target

Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation

Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.)

Role of NKG2D and its ligands in cancer immunotherapy.

Important Flavonoids and Their Role as a Therapeutic Agent

Glycogen Synthase Kinase 3β Regulates Cell Death Induced by Synthetic Triterpenoids

Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor V  2 T lymphocytes in non-Hodgkin lymphomas

Celecoxib induces proliferation and Amphiregulin production in colon subepithelial myofibroblasts, activating erk1–2 signaling in synergy with EGFR

Prostaglandin-endoperoxide synthase 2 (cyclooxygenase-2), a complex target for colorectal cancer prevention and therapy

ADAM10 new selective inhibitors reduce NKG2D ligand release sensitizing Hodgkin lymphoma cells to NKG2D-mediated killing

Xanthohumol Impairs Human Prostate Cancer Cell Growth and Invasion and Diminishes the Incidence and Progression of Advanced Tumors in TRAMP Mice

The AKT/NF-κB inhibitor xanthohumol is a potent anti-lymphocytic leukemia drug overcoming chemoresistance and cell infiltration